Previous 10 | Next 10 |
This article series has been releasing every month since 2015 a dashboard with aggregate industry metrics in healthcare (most popular ETFs in this sector: XLV , IYH , IBB , XBI , VHT , XPH ). Shortcut If you are used to this dashboard series or if you are short of time, you can s...
( Pexels ) Of all the investable sectors and industries, one of the top-performing over the past few months is biotechnology. Since its March low (18 th ), the SPDR Biotech ETF ( XBI ) has risen about 75% as investors speculate on virus treatment and vaccine rumors. Understandably, many in...
Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants to invest in multiple biotech companies via one vehicle. The life science sector certainly holds a risk factor, and ETFs are a good way to enter th...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , June 17, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that key data from the INCREASE study of Tyvaso ® (treprostinil) Inhalation Solution in patients suffering from World Health Or...
There are Those Who Still Believe in Afrezza: MannKind’s ( MNKD ) single product, Afrezza, was launched into the market during the last week of January 2015. Now, 5.3 years later, the product is generating the same level, or less, in total weekly prescription as seen in 2015. For ...
United Therapeutics (NASDAQ: UTHR ) has filed a lawsuit in Delaware district court against Liquidia Technologies (NASDAQ: LQDA ) for infringement of the following patents relating to company's Tyvaso (treprostinil) Inhalation Solution: U.S. Patent Nos. 9,604,901 and 9,593,066, both of...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , June 5, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it has filed a lawsuit in the U.S. District Court for the District of Delaware against Liquidia Technologies, Inc. (Liqui...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , May 26, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that Mr. James Edgemond , Chief Financial Officer and Treasurer of United Therapeutics, will provide an overview and update on the comp...
The sheer volume of biotech IPOs over the past few years makes it challenging to keep up to date on all these newly public companies. Several have returned to the capital markets to load up on cash to fund ongoing research and development (R&D) efforts. Among this crowd, Y-mAbs Therapeutics...
The following slide deck was published by United Therapeutics Corporation in conjunction with this Read more ...
News, Short Squeeze, Breakout and More Instantly...
United Therapeutics Corporation Company Name:
UTHR Stock Symbol:
NASDAQ Market:
United Therapeutics Corporation Website:
A look at the top 10 most actives in the United States Aptevo Therapeutics Inc. (APVO) rose 45.1% to $0.486 on volume of 64,992,551 shares Verb Technology Company Inc. (VERB) rose 3.5% to $0.1205 on volume of 54,410,242 shares NVIDIA Corporation (NVDA) fell 4.4% to $120.752 on volume of 4...
2024-07-11 06:30:06 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for UTHR on July 11, 2024 04:53AM ET. The previous analyst recommendation was Overweight. UTHR was trading at $329.25 at issue of the analyst recommendation. The overall analyst consensus : ...
Over 100,000 patients in the United States have IPF, with two approved therapies available that only slow the course of disease progression Top line data expected in the second half of 2025 United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announ...